title: Effect of ambient temperature on the thermoregulatory and locomotor stimulant effects of 4-methylmethcathinone in Wistar and Sprague-Dawley rats.
abstract: The drug 4-methylmethcathinone (4-MMC; aka, mephedrone, MMCAT, "plant food", "bath salts") is a recent addition to the list of popular recreational psychomotor-stimulant compounds. Relatively little information about this drug is available in the scientific literature, but popular media reports have driven recent drug control actions in the UK and several US States. Online user reports of subjective similarity to 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") prompted the current investigation of the thermoregulatory and locomotor effects of 4-MMC. Male Wistar and Sprague-Dawley rats were monitored after subcutaneous administration of 4-MMC (1-10 mg/kg ) using an implantable radiotelemetry system under conditions of low (23°C) and high (27°C) ambient temperature. A reliable reduction of body temperature was produced by 4-MMC in Wistar rats at 23°C or 27°C with only minimal effect in Sprague-Dawley rats. Increased locomotor activity was observed after 4-MMC administration in both strains with significantly more activity produced in the Sprague-Dawley strain. The 10 mg/kg s.c. dose evoked greater increase in extracellular serotonin, compared with dopamine, in the nucleus accumbens. Follow-up studies confirmed that the degree of locomotor stimulation produced by 10 mg/kg 4-MMC was nearly identical to that produced by 1 mg/kg d-methamphetamine in each strain. Furthermore, hypothermia produced by the serotonin 1(A/7) receptor agonist 8-hydroxy-N,N-dipropyl-2-aminotetralin (8-OH-DPAT) was similar in each strain. These results show that the cathinone analog 4-MMC exhibits thermoregulatory and locomotor properties that are distinct from those established for methamphetamine or MDMA in prior work, despite recent evidence of neuropharmacological similarity with MDMA.
authors.affiliation: Committee on Neurobiology of Addictive Disorders, The Scripps Research Institute, La Jolla, California, USA.
authors.forename: M Jerry
authors.initials: MJ
authors.lastname: Wright
authors.forename: Deepshikha
authors.initials: D
authors.lastname: Angrish
authors.forename: Shawn M
authors.initials: SM
authors.lastname: Aarde
authors.forename: Deborah J
authors.initials: DJ
authors.lastname: Barlow
authors.forename: Matthew W
authors.initials: MW
authors.lastname: Buczynski
authors.forename: Kevin M
authors.initials: KM
authors.lastname: Creehan
authors.forename: Sophia A
authors.initials: SA
authors.lastname: Vandewater
authors.forename: Loren H
authors.initials: LH
authors.lastname: Parsons
authors.forename: Karen L
authors.initials: KL
authors.lastname: Houseknecht
authors.forename: Tobin J
authors.initials: TJ
authors.lastname: Dickerson
authors.forename: Michael A
authors.initials: MA
authors.lastname: Taffe
mesh_terms: D017371:8-Hydroxy-2-(di-n-propylamino)tetralin / Q000008:administration & dosage / Q000494:pharmacology; D000818:Animals; D001833:Body Temperature Regulation / Q000187:drug effects*; D000697:Central Nervous System Stimulants / Q000008:administration & dosage / Q000494:pharmacology*; D004298:Dopamine / Q000378:metabolism; D007279:Injections, Subcutaneous; D008124:Locomotion / Q000187:drug effects*; D008297:Male; D008694:Methamphetamine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000097:blood / Q000493:pharmacokinetics / Q000494:pharmacology; D017551:Microdialysis; D009714:Nucleus Accumbens / Q000187:drug effects / Q000502:physiology; D011427:Propiophenones / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D017208:Rats, Wistar; D012701:Serotonin / Q000378:metabolism; D013696:Temperature; D013997:Time Factors
chemical_list: D000697:Central Nervous System Stimulants; D011427:Propiophenones; D012701:Serotonin; C047806:monomethylpropion; D008694:Methamphetamine; D017371:8-Hydroxy-2-(di-n-propylamino)tetralin; C548233:mephedrone; D004298:Dopamine